Home > News > ACLARA Signs GlaxoSmithKline to eTag™ Access Agreement
July 30th, 2003
ACLARA Signs GlaxoSmithKline to eTag™ Access Agreement
Abstract:
ACLARA BioSciences announced today that it has entered into an eTag™ Access Agreement with GlaxoSmithKline (GSK), under which GSK will gain access to ACLARA's proprietary eTag Assay System for use in its biopharmaceutical research and development activities.
Source:
ACLARA
Related News Press |
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||